Task: Answer the multiple choice question.
Question: Which drug exhibits a 1.800\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CC(C)(C)c1ccc(NC(=O)COC(=O)c2ccc(CN3CCCC3=O)cc2)cc1
(b) O=C(Nc1ccc(F)cc1)C1C(c2ccccc2)C1(Cl)Cl
Answer: a. CC(C)(C)c1ccc(NC(=O)COC(=O)c2ccc(CN3CCCC3=O)cc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)(C)c1ccc(NC(=O)COC(=O)c2ccc(CN3CCCC3=O)cc2)cc1
CC(C)(C)c1ccc(NC(=O)COC(=O)c2ccc(CN3CCCC3=O)cc2)cc1
[2-(4-tert-butylanilino)-2-oxoethyl] 4-[(2-oxopyrrolidin-1-yl)methyl]benzoate